Cavanaugh Group, Inc.’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.47M Buy
+118,850
New +$3.16M 1.25% 19

Other funds holding PFE

Cavanaugh Group, Inc.'s PFE Position: Q3 2026 in Review

Cavanaugh Group, Inc. opened a new position in Pfizer (PFE) in Q3 2026: 118,850 shares worth $3.47M. The stake represents 1.25% of the portfolio and ranks #19 among its holdings.

2,899 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Cavanaugh Group, Inc. held 118,850 shares of Pfizer worth $3.47M as of Q3 2026.
  • Pfizer was a new Cavanaugh Group, Inc. position in Q3 2026.
  • Pfizer made up 1.25% of Cavanaugh Group, Inc.'s portfolio in Q3 2026, its #19 holding.
  • 2,899 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Cavanaugh Group, Inc.'s 13F filing for Q3 2026, filed 17 Nov 2026.